Andreas A. Linninger

University of Illinois at Chicago, Chicago, Illinois, United States

Are you Andreas A. Linninger?

Claim your profile

Publications (105)123.27 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: There is an ongoing struggle to develop efficient drug delivery and targeting methods within the central nervous system. One technique known as intrathecal drug delivery, involves direct drug infusion into the spinal canal and has become standard practice for treating many central nervous system diseases due to reduced systemic toxicity from the drug bypassing the blood-brain barrier. Although intrathecal drug delivery boasts the advantage of reduced systemic toxicity compared to oral and intravenous drug delivery techniques, current intrathecal delivery protocols lack a means of sufficient drug targeting at specific locations of interest within the central nervous system. We previously proposed the method of intrathecal magnetic drug targeting in order to overcome the limited targeting capabilities of standard intrathecal drug delivery protocols, while simultaneously reducing the systemic toxicity as well as the amount of drug required to produce a therapeutic effect. Building off of our previous work, this paper presents the concept of implant-assisted intrathecal magnetic drug targeting. Ferritic stainless steel implants were incorporated within the subarachnoid space of our in vitro human spine model, and the targeting magnet was placed at a physiological distance away from the model and implant to mimic the distance between the epidermis and spinal canal. Computer simulations were performed to optimize implant design for generating high gradient magnetic fields and to study how these fields may aid in therapeutic nanoparticle localization. Experiments aiming to determine the effects of different magnetically-susceptible implants placed within an external magnetic field on the targeting efficiency of gold-coated magnetite nanoparticles were then performed on our in vitro human spine model. Our results indicate that implant-assisted intrathecal magnetic drug targeting is an excellent supplementary technique to further enhance the targeting capabilities of our previously established method of intrathecal magnetic drug targeting.
    Journal of Biomedical Nanotechnology 02/2015; 11(2). · 7.58 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Extracranial CSF shunt obstruction is one of the most important problems in hydrocephalus patient management. Despite ongoing research into better shunt design, robust and reliable detection of shunt malfunction remains elusive. The authors present a novel method of correlating degree of tissue ingrowth into ventricular CSF drainage catheters with internal electrical impedance. The impedance based sensor is able to continuously monitor shunt patency using intraluminal electrodes. Prototype obstruction sensors were fabricated for in-vitro analysis of cellular ingrowth into a shunt under static and dynamic flow conditions. Primary astrocyte cell lines and C6 glioma cells were allowed to proliferate up to 7 days within a shunt catheter and the impedance waveform was observed. During cell ingrowth a significant change in the peak-to-peak voltage signal as well as the root-mean-square voltage level was observed, allowing the impedance sensor to potentially anticipate shunt malfunction long before it affects fluid drainage. Finite element modeling was employed to demonstrate that the electrical signal used to monitor tissue ingrowth is contained inside the catheter lumen and does not endanger tissue surrounding the shunt. These results may herald the development of "next generation" shunt technology that allows prediction of malfunction before it affects patient outcome.
    IEEE transactions on bio-medical engineering 07/2014; · 2.15 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Improvement in cerebral perfusion post endovascular treatment of vasospasm in patients with aneurysmal subarachnoid haemorrhage (aSAH) is typically assessed by comparison of major vessel diameters on digital subtraction angiography (DSA). In this report we sought to assess relative changes in cerebral blood flow by computational DSA transit time (TT) analysis in patients with cerebral vasospasm before/after endovascular treatment.
    Journal of Neurointerventional Surgery 07/2014; 6 Suppl 1:A27-8. · 2.50 Impact Factor
  • Ian G. Gould, Andreas A. Linninger
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective Oxygen tension in the brain is controlled by the microcirculatory supply of red blood cells, but the effect of non-Newtonian blood flow rheology on tissue oxygenation is not well characterized. This paper assesses different biphasic blood flow models for predicting tissue oxygen tension as a function of microcirulatory hemodynamics.Methods Two existing plasma skimming laws are compared against measured RBC distributions in rat and hamster microcirculatory networks. A novel biphasic blood flow model is introduced. The computational models predict tissue oxygenation in the mesentery, cremaster muscle, and the human secondary cortex.ResultsThis investigation shows deficiencies in prior models, including inconsistent plasma skimming trends and insufficient oxygen perfusion due to the high prevalence (33%) of RBC-free microvessels. Our novel method yields physiologically sound RBC distributions and tissue oxygen tensions within one standard deviation of experimental measurements.ConclusionsA simple, novel biphasic blood flow model is introduced with equal or better predictive power when applied to historic raw data sets. It can overcome limitations of prior models pertaining to trifurcations, anastomoses, and loops. This new plasma skimming law eases the computations of bulk blood flow and hematocrit fields in large microcirculatory networks and converges faster than prior procedures.This article is protected by copyright. All rights reserved.
    Microcirculation (New York, N.Y.: 1994) 07/2014; · 2.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The use of digital subtraction angiography (DSA) for semi-quantitative cerebral blood flow (CBF) assessment is a new method. In this report we sought to correlate angiographic transit times (TT) in patients with aneurysmal subarachnoid haemorrhage (aSAH) in relation to Hunt &Hess (H&H) grade.
    Journal of Neurointerventional Surgery 07/2014; 6 Suppl 1:A64-5. · 2.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aim: We aimed to magnetically guide and locally confine nanoparticles in desired locations within the spinal canal to achieve effective drug administration for improved treatment of chronic pain, cancers, anesthesia and spasticity. Materials & methods: We developed a physiologically and anatomically consistent in vitro human spine model to test the feasibility of intrathecal magnetic drug targeting. Gold-coated magnetite nanoparticles were infused into the model and targeted to specific regions using external magnetic fields. Experiments and simulations aiming to determine the effect of key parameters, such as magnet strength, duration of magnetic field exposure, magnet location and ferrous implants, on the collection efficiency of superparamagnetic nanoparticles in targeted regions were performed. Results: An 891% increase in nanoparticle collection efficiency within the target region was achieved using intrathecal magnetic drug targeting when compared with the control. Nanoparticle collection efficiency at the target region increased with time and reached a steady value within 15 min. Ferrous epidural implants generated sufficiently high-gradient magnetic fields, even when magnets were placed at a distance equal to the space between a patient's epidermis and spinal canal. Conclusion: Our experiments indicate that intrathecal magnetic drug targeting is a promising technique for concentrating and localizing drugs at targeted sites within the spinal canal for treating diseases affecting the CNS. Original submitted 27 June 2012; Revised submitted 11 March 2013.
    Nanomedicine 07/2013; · 5.26 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The three-dimensional spatial arrangement of the cortical microcirculatory system is critical for understanding oxygen exchange between blood vessels and brain cells. A three-dimensional computer model of a 3 × 3 × 3 mm(3) subsection of the human secondary cortex was constructed to quantify oxygen advection in the microcirculation, tissue oxygen perfusion, and consumption in the human cortex. This computer model accounts for all arterial, capillary and venous blood vessels of the cerebral microvascular bed as well as brain tissue occupying the extravascular space. Microvessels were assembled with optimization algorithms emulating angiogenic growth; a realistic capillary bed was built with space filling procedures. The extravascular tissue was modeled as a porous medium supplied with oxygen by advection-diffusion to match normal metabolic oxygen demand. The resulting synthetic computer generated network matches prior measured morphometrics and fractal patterns of the cortical microvasculature. This morphologically accurate, physiologically consistent, multi-scale computer network of the cerebral microcirculation predicts the oxygen exchange of cortical blood vessels with the surrounding gray matter. Oxygen tension subject to blood pressure and flow conditions were computed and validated for the blood as well as brain tissue. Oxygen gradients along arterioles, capillaries and veins agreed with in vivo trends observed recently in imaging studies within experimental tolerances and uncertainty.
    Annals of Biomedical Engineering 07/2013; · 3.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Unknown dose regimes are typically assessed on animals prior to clinical trials. Recent advances in the evaluation of new leads’ efficacy have been achieved by pharmacokinetic modeling. Further improvements, including determination of the drug's mechanism of action and organism biodistribution, require an effective methodology for solving parameter estimation challenges. This article solves the problem of rigorously estimating unknown biochemical reaction and transport parameters from in vivo datasets and identifying whole-body physiologically based pharmacokinetic (PBPK) models.A rat blood circulation model was combined with biotransport, biochemical reactions and metabolism of the immunosuppressant Cyclosporin. We demonstrate the proposed methodology on a case study in Sprague-Dawley rats by bolus iv injections of 1.2, 6 and 30 mg/kg. Key pharmacokinetic parameters were determined, including renal and hepatic clearances, elimination half-life, and mass transfer coefficients, to establish drug biodistribution dynamics in all organs and tissues. This multi-scale model satisfies first principles and conservation of mass, species and momentum.Prediction of organ drug bioaccumulation as a function of cardiac output, physiology, pathology or administration route may be possible with the proposed PBPK framework. Successful application of our model-based drug development method may lead to more efficient preclinical trials, accelerated knowledge gain from animal experiments, and shortened time-to-market of new drugs.
    Computers & Chemical Engineering 07/2013; 54:97-110. · 2.09 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Object Experimental data about the evolution of intracranial volume and pressure in cases of hydrocephalus are limited due to the lack of available monitoring techniques. In this study, the authors validate intracranial CSF volume measurements within the lateral ventricle, while simultaneously using impedance sensors and pressure transducers in hydrocephalic animals. Methods A volume sensor was fabricated and connected to a catheter that was used as a shunt to withdraw CSF. In vitro bench-top calibration experiments were created to provide data for the animal experiments and to validate the sensors. To validate the measurement technique in a physiological system, hydrocephalus was induced in weanling rats by kaolin injection into the cisterna magna. At 28 days after induction, the sensor was implanted into the lateral ventricles. After sealing the skull using dental cement, an acute CSF drainage/infusion protocol consisting of 4 sequential phases was performed with a pump. Implant location was confirmed via radiography using intraventricular iohexol contrast administration. Results Controlled CSF shunting in vivo with hydrocephalic rats resulted in precise and accurate sensor measurements (r = 0.98). Shunting resulted in a 17.3% maximum measurement error between measured volume and actual volume as assessed by a Bland-Altman plot. A secondary outcome confirmed that both ventricular volume and intracranial pressure decreased during CSF shunting and increased during infusion. Ventricular enlargement consistent with successful hydrocephalus induction was confirmed using imaging, as well as postmortem. These results indicate that volume monitoring is feasible for clinical cases of hydrocephalus. Conclusions This work marks a departure from traditional shunting systems currently used to treat hydrocephalus. The overall clinical application is to provide alternative monitoring and treatment options for patients. Future work includes development and testing of a chronic (long-term) volume monitoring system.
    Journal of Neurosurgery Pediatrics 08/2012; 10(4):347-54. · 1.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Intrathecal drug delivery is an efficient method to administer therapeutic molecules to the central nervous system. However, even with identical drug dosage and administration mode, the extent of drug distribution in vivo is highly variable and difficult to control. Different cerebrospinal fluid (CSF) pulsatility from patient to patient may lead to different drug distribution. Medical image-based computational fluid dynamics (miCFD) is used to construct a patient-specific model to quantify drug transport as a function of a spectrum of physiological CSF pulsations. Magnetic resonance imaging (MRI) and CINE MRI were performed to capture the patient's central nervous system anatomy and CSF pulsatile flow velocities. An miCFD model was reconstructed from these MRIs and the patient's CSF flow velocities were computed. The effect of CSF pulsatility (frequency and stroke volume) was investigated for a bolus injection of a model drug at the L2 vertebral level. Drug distribution profiles along the entire spine were computed for different heart rates: 43, 60, and 120 bpm, and varied CSF stroke volumes: 1, 2, and 3 mL. To assess toxicity risk for patients with different physiological variables, therapeutic and toxic concentration thresholds for a common anesthetic were derived from experimental studies. Toxicity risk analysis was performed for an injection of a spinal anesthetic for patients with different heart rates and CSF stroke volumes. Both heart rate and CSF stroke volume of the patient strongly influence drug distribution administered intrathecally. Doubling the heart rate (from 60 to 120 bpm) caused a 26.4% decrease in peak concentration in CSF after injection. Doubling the CSF stroke volume diminished the peak concentration after injection by 38.1%. Computations show that potentially toxic peak concentrations due to injection can be avoided by changing the infusion rate. Using slower infusion rates could avoid high peak concentrations in CSF while maintaining drug concentrations above the therapeutic threshold. Our computations identify key variables for patient to patient variability in drug distribution in the spine observed clinically. The speed of drug transport is strongly affected by the frequency and magnitude of CSF pulsations. Toxicity risks associated with an injection can be reduced for a particular patient by adjusting the infusion variables with our rigorous miCFD model.
    Anesthesia and analgesia 04/2012; 115(2):386-94. · 3.08 Impact Factor
  • Oleksandr Ivanchenko, Nikhil Sindhwani, Andreas A. Linninger
    AIChE Journal 04/2012; 58(4). · 2.58 Impact Factor
  • Andreas A. Linninger
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent advances in quantitative imaging allow unprecedented views into cellular chemistry of whole organisms in vivo. These novel imaging modalities enable the quantitative investigation of spatio-temporal reaction and transport phenomena in the living animal or the human body. This article will highlight the significant role that rigorous systems engineering methods can play for interpreting the wealth of in vivo measurements. A methodology to integrate medical imaging modalities with rigorous computational fluid dynamics entitled image-based computational fluid dynamics (iCFD) will be introduced. The quantitative analysis of biological systems with rigorous mathematical methods is expected to accelerate the introduction of novel drugs by providing a rational foundation for the systematic development of new medical therapies. Rigorous engineering methods not only advance biomedical research, but also aid the translation of laboratory research results into the bedside practice.
    Computers & Chemical Engineering 01/2012; · 2.09 Impact Factor
  • Daniel A. Beneke, Seon B. Kim, Andreas A. Linninger
    [Show abstract] [Hide abstract]
    ABSTRACT: Rising energy costs and growing environmental awareness motivate a critical revision of the design of distillation units. Systematic design techniques, such as the rectification body, column profile map, and temperature collocation methods, require exact knowledge of all pinch points in a particular system, because these stationary points delineate the possible composition trajectories realizable in separation columns. This paper demonstrates novel methods for rigorously determining all pinch points for the constant relative volatility, ideal and non-ideal systems. Constant relative volatility and ideal solution systems are transformed into one-dimensional polynomial and nonlinear functions, regardless of the number of the components. A deflation method is proposed to locate all zeros in ideal and non-ideal zeotropic problems. For more challenging non-ideal problems, a novel hybrid sequential niche algorithm is used to solve hard azeotropic problems successfully. Finally, the design implications of these pinch point locations are investigated to show how new separation configurations can be devised. Methodically the paper points out the use of rigorous pinch point computations in conjunction with continuous composition profiles for robust distillation design.
    Chinese Journal of Chemical Engineering. 12/2011; 19(6):911–925.
  • Cierra Hall, Eric Lueshen, Andrej Mošat, Andreas A Linninger
    [Show abstract] [Hide abstract]
    ABSTRACT: Drug approval processes require extensive testing and have recently put more emphasis on understanding mechanistic drug action in the body including toxicity and safety.1 Consequently, there is an urgent need in the pharmaceutical industry to develop mechanistic pharmacokinetic (PK) models able to both expedite knowledge gain from experimental trials and, simultaneously, address safety concerns. We previously developed a first principles based whole-body PK model, which incorporated physiological dimensions and drug mass transport. In this follow-up article, we demonstrate how the first principles model in combination with novel physiological scaling laws yields more reliable interspecies and intraspecies extrapolation of drug biodistribution. We show how experimental dose-response data in rats for immunosuppressant cyclosporin are sufficient for predicting the biodistribution of this drug in pigs, monkeys, and humans. The predicted drug concentrations extrapolated by interspecies scaling laws match well with the experimental measurements. These promising results demonstrate that the whole-body PK modeling approach not only elucidates drug mechanisms from a biochemical standpoint, but offers better scaling precision. Better models can substantially accelerate the introduction of drug leads to clinical trials and eventually to the market by offering more understanding of the drug mechanisms, aiding in therapy design, and serving as an accurate dosing tool.
    Journal of Pharmaceutical Sciences 11/2011; 101(3):1221-41. · 3.13 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Whole body physiologically-based pharmacokinetic (PBPK) modeling attempts to model the uptake and distribution of a drug inside the body. Traditionally, pharmacokinetic models have been developed by simple curve fitting of experimental data without considering the mechanistic and physics of the system. The drawback of such models is their lack of physical insights and the pure extrapolation features to untested conditions, to other drugs as well as to individuals of the same species or different species. Lately, PBPK models, which are based on first principles, have received increasing attention. In this work, a first principles engineering approach to PBPK modeling that is based on conservation equations and advanced scaling laws is proposed. The developed global pharmacokinetic models are based on biochemical, anatomical and physiological data. The resulting PBPK models are able to extrapolate and scale between species and individuals because they are based on actual occurring physical mechanisms and allow the application of more advanced scaling laws than just considering the differing masses of the individuals. Due to their improved scaling qualities, first principles PBPK models have the potential to reduce the number of undesirable as well as time- and cost-intensive animal experiments during the drug development phase. Further, the development of first principle-based PBPK models leads to a gain of insight in the occurring processes during drug uptake by an organism. Having these models at hand moreover allows the determination of accurate and optimal drug dosage for desired therapeutic effects. However, the development of first principles PBPK models, their identification, and discrimination between different candidate models is a non-trivial task inherent with a number of challenges which are related to identifying the occurring mechanisms inside the body and the appropriate degrees of detail of the models with respect to the modeling goal and the available experimental data: Firstly, a large number of alternative PBPK models can be generated depending on the degree of detail considered and the assumptions made about the different considered mechanisms in the body. Further, first principle PBPK models are usually complex models which contain a large number of unknown parameters that are not always all identifiable by the limited experimental data accessible. A strategy needs to be found to address the problem of discriminating between the different candidate models and identifying their parameters in order to find the model that is best supported by the experimental data available. In this context, design of experiments for model discrimination and parameter estimation plays an important role. If the models cannot be discriminated based on the available data, or model parameters that are important for the desired model outputs are not identifiable by the available data, methods for optimal design of experiments need to be applied. Design of experiments is especially important in pharmacokinetic modeling because in order to obtain the required datapoints animals need to be sacrificed. In this work, a systematic methodology for the development, analysis, identification (including sensitivity analysis, identifiability analysis and parameter estimation) and discrimination between different pharmacokinetic candidate models is proposed. The methodology is implemented into a computer-aided modeling framework. The benefit of the proposed systematic approach is an improvement of model quality and an increase of efficiency of the modeler as well as the experimentalist and thereby a reduction of time and resources required for model development, identification, discrimination and application. This is achieved by designing the structure of the computer-aided modeling framework such that it can handle the work-flows and data-flows associated with the different modeling tasks, combining state-of-the-art modeling techniques for the different work-flow steps as well as supporting model-documentation and model reuse. The proposed modeling framework for PBPK modeling is highlighted through a case study which deals with the development of a PBPK model for a rat based on available experimental data.
    2011 AIChE Annual Meeting; 10/2011
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Clinical studies have shown that drugs delivered intrathecally distribute much faster than can be accounted for by pure molecular diffusion. However, drug transport inside the cerebrospinal fluid (CSF)-filled spinal canal is poorly understood. In this study, comprehensive experimental and computational studies were conducted to quantify the effect of pulsatile CSF flow on the accelerated drug dispersion in the spinal canal. Infusion tests with a radionucleotide and fluorescent dye under stagnant and pulsatile flow conditions were conducted inside an experimental surrogate model of the human spinal canal. The tracer distributions were quantified optically and by single photon emission computed tomography (SPECT). The experimental results show that CSF flow oscillations substantially enhance fluorescent dye and radionucleotide dispersion in the spinal canal experiment. The experimental observations were interpreted by rigorous computer simulations. To demonstrate the clinical significance, the dispersion of intrathecally infused baclofen, an anti-spasticity drug, was predicted by using patient-specific spinal data and CSF flow measurements. The computational predictions are expected to enable the rational design of intrathecal drug therapies.
    Annals of Biomedical Engineering 08/2011; · 3.23 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Clinical studies have shown that drugs delivered intrathecally distribute much faster than can be accounted for by pure molecular diffusion. However, drug transport inside the cerebrospinal fluid (CSF)-filled spinal canal is poorly understood. In this study, comprehensive experimental and computational studies were conducted to quantify the effect of pulsatile CSF flow on the accelerated drug dispersion in the spinal canal. Infusion tests with a radionucleotide and fluorescent dye under stagnant and pulsatile flow conditions were conducted inside an experimental surrogate model of the human spinal canal. The tracer distributions were quantified optically and by single photon emission computed tomography (SPECT). The experimental results show that CSF flow oscillations substantially enhance fluorescent dye and radionucleotide dispersion in the spinal canal experiment. The experimental observations were interpreted by rigorous computer simulations. To demonstrate the clinical significance, the dispersion of intrathecally infused baclofen, an anti-spasticity drug, was predicted by using patient-specific spinal data and CSF flow measurements. The computational predictions are expected to enable the rational design of intrathecal drug therapies.
    Annals of Biomedical Engineering 07/2011; 39(10):2592-602. · 3.23 Impact Factor
  • Sukhraaj S Basati, Timothy J Harris, Andreas A Linninger
    [Show abstract] [Hide abstract]
    ABSTRACT: Knowledge of intracranial ventricular volume is important for the treatment of hydrocephalus, a disease in which cerebrospinal fluid (CSF) accumulates in the brain. Current monitoring options involve MRI or pressure monitors (InSite, Medtronic). However, there are no existing methods for continuous cerebral ventricle volume measurements. In order to test a novel impedance sensor for direct ventricular volume measurements, we present a model that emulates the expansion of the lateral ventricles seen in hydrocephalus. To quantify the ventricular volume, sensor prototypes were fabricated and tested with this experimental model. Fluid was injected and withdrawn cyclically in a controlled manner and volume measurements were tracked over 8 h. Pressure measurements were also comparable to conditions seen clinically. The results from the bench-top model served to calibrate the sensor for preliminary animal experiments. A hydrocephalic rat model was used to validate a scaled-down, microfabricated prototype sensor. CSF was removed from the enlarged ventricles and a dynamic volume decrease was properly recorded. This method of testing new designs on brain phantoms prior to animal experimentation accelerates medical device design by determining sensor specifications and optimization in a rational process.
    IEEE transactions on bio-medical engineering 05/2011; 58(5):1450-5. · 2.15 Impact Factor
  • Jeonghwa Moon, Seon Kim, Andreas A. Linninger
    [Show abstract] [Hide abstract]
    ABSTRACT: High-performance processes require a design that operates close to design boundaries and specifications, while still guaranteeing robust performance without design constraint violations. In order to safely approach tighter boundaries of process performance, much attention has been devoted to integrating design and control in which dynamic controllability, as well as the design decisions, are considered simultaneously. However, rigorous methods solving design and control simultaneously lead to challenging mathematical formulations that easily become intractable numerically and computationally. This paper introduces a new mathematical formulation to reduce this combinatorial complexity of integrating design and control. We will show that a substantial reduction in problem size can be achieved using embedded control decisions within specific designs. These embedded control decisions avoid a combinatorial explosion of control configuration, using a full state space model that does not require a pairing of control variables and loops. The current capabilities of the methodology will be demonstrated using a realistic reactor−column flowsheet.
    04/2011;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Convection-enhanced delivery (CED) is a promising technique to deliver large molecular weight drugs to the human brain for treatment of Parkinson's, Alzheimer's, or brain tumors. Researchers have used agarose gels to study mechanisms of agent transport in soft tissues like brain due to its similar mechanical and transport properties. However, inexpensive quantitative techniques to precisely measure achieved agent distribution in agarose gel phantoms during CED are missing. Such precise measurements of concentration distribution are needed to optimize drug delivery. An optical experimental method to accurately quantify agent concentration in agarose is presented. A novel geometry correction algorithm is used to determine real concentrations from observable light intensities captured by a digital camera. We demonstrate the technique in dye infusion experiments that provide cylindrical and spherical distributions when infusing with porous membrane and conventional single-port catheters, respectively. This optical method incorporates important parameters, such as optimum camera exposure, captured camera intensity calibration, and use of collimated light source for maximum precision. We compare experimental results with numerical solutions to the convection diffusion equation. The solutions of convection-diffusion equations in the cylindrical and spherical domains were found to match the experimental data obtained by geometry correction algorithm.
    IEEE transactions on bio-medical engineering 03/2011; 58(3):626-32. · 2.15 Impact Factor

Publication Stats

636 Citations
123.27 Total Impact Points

Institutions

  • 1998–2014
    • University of Illinois at Chicago
      • • Department of Bioengineering
      • • Department of Chemical Engineering
      Chicago, Illinois, United States
  • 2007–2009
    • University of Chicago
      • Department of Surgery
      Chicago, IL, United States
  • 2008
    • University of Rhode Island
      Kingston, Rhode Island, United States
  • 2006
    • Michigan State University
      • Department of Psychology
      East Lansing, MI, United States
  • 1995–1996
    • Massachusetts Institute of Technology
      • Department of Chemical Engineering
      Cambridge, MA, United States